Related references
Note: Only part of the references are listed.Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
George Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health
George H. Talbot et al.
CLINICAL INFECTIOUS DISEASES (2012)
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
David R. Andes et al.
CLINICAL INFECTIOUS DISEASES (2012)
Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis
Ching-Lan Lu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin
Jennifer D. Twilla et al.
JOURNAL OF HOSPITAL MEDICINE (2012)
Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents
J. A. McKinnell et al.
EPIDEMIOLOGY AND INFECTION (2011)
High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
Ravina Kullar et al.
PHARMACOTHERAPY (2011)
Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients
Shawna Kraft et al.
SUPPORTIVE CARE IN CANCER (2011)
The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Mini Kamboj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Management of multidrug-resistant enterococcal infections
C. A. Arias et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Comparison of Outcomes From Daptomycin or Linezolid Treatment for Vancomycin-Resistant Enterococcal Bloodstream Infection: A Retrospective, Multicenter, Cohort Study
Christopher W. Crank et al.
CLINICAL THERAPEUTICS (2010)
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Pamela A. Moise et al.
ANNALS OF PHARMACOTHERAPY (2009)
Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000-2006
Andrew M. Ramsey et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Vidya Mave et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia
Kristine Mace Erlandson et al.
CLINICAL INFECTIOUS DISEASES (2008)
The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004
Rebecca Reik et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Alicia I. Hidron et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci:: a Phase 3, multicentre, double-blind, randomized study
I. Florescu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype
Jae-Hoon Song et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium Bacteremia in cancer patients
G. Ghanem et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality
Bernard C. Camins et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program
Lalitagauri M. Deshpande et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant
David M. Weinstock et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection
CA DiazGranados et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens
CF Carpenter et al.
CLINICAL INFECTIOUS DISEASES (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide
HS Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs
XY Song et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Linezolid: The first oxazolidinone antimicrobial
RC Moellering
ANNALS OF INTERNAL MEDICINE (2003)
Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program
MC Birmingham et al.
CLINICAL INFECTIOUS DISEASES (2003)
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study
EN Vergis et al.
ANNALS OF INTERNAL MEDICINE (2001)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
SM Bhavnani et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia
JM Garbutt et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
